Gilead Sciences
GILD
$67.08
Share price
0.07%
Change (1 day)
-22.63%
Change (1 year)
Categories
Operating Margin for Gilead Sciences (GILD)
Operating Margin as of April 2024 (TTM): 26.84%
According to Gilead Sciences's latest financial reports and stock price the company's current Operating Margin is 26.84%. At the end of 2022 the company had an Operating Margin of 21.31%.
Operating Margin history for Gilead Sciences from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 21.31% | -29.7% |
| 2021 | 30.32% | 348.47% |
| 2020 | 6.76% | -70.59% |
| 2019 | 22.99% | -34.79% |
| 2018 | 35.25% | -31.98% |
| 2017 | 51.82% | -7.89% |
| 2016 | 56.26% | -15.22% |
| 2015 | 66.36% | 11.18% |
| 2014 | 59.69% | 58.88% |
| 2013 | 37.57% | 0.91% |
| 2012 | 37.23% | -14.5% |
| 2011 | 43.54% | -11.56% |
| 2010 | 49.23% | -1.43% |
| 2009 | 49.95% | -2.54% |
| 2008 | 51.25% | -4.52% |
| 2007 | 53.67% | -354.49% |
| 2006 | -21.09% | -136.82% |
| 2005 | 57.28% | 15.58% |
| 2004 | 49.56% | -356.71% |
| 2003 | -19.30% | -222.77% |
| 2002 | 15.72% | -36.02% |
| 2001 | 24.57% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -14.75% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | 28.95% | 🇺🇸 USA |
 AbbVie ABBV | 18.65% | -30.51% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -8.12% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 28.87% | 🇺🇸 USA |
 Biogen BIIB | 31.30% | 16.62% | 🇺🇸 USA |
 Illumina ILMN | -94.58% | -452.38% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | 47.39% | 76.56% | 🇺🇸 USA |
 Merck MRK | 27.73% | 3.32% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.